In vitro ADME testing services market is likely to be worth USD 2.2 billion by 2030, growing at an annualized rate of ~9.8%, predicts Roots Analysis
Roots Analysis is pleased to announce the publication of its recent study, titled, “In Vitro ADME Testing Services Market, 2019-2030” …
Read MoreThe non-invasive cancer diagnostics market is estimated to be worth around USD 20.1 billion by 2030.
Liquid biopsies have emerged as a versatile diagnostic solution, especially for cases when conventional (invasive) diagnostic tests are inconclusive or …
Read MoreThe drug repurposing service providers market, predicts Roots Analysis
Drug repurposing enables drug developers to optimize on past efforts and expenditure, thereby, offering a viable life cycle management strategy …
Read MorePresently, over 65 companies claim to offer drug repurposing-related services to the global pharmaceutical industry
Repurposing of marketed / shelved / pipeline candidates for the treatment of diseases (different from original target indications) has emerged …
Read MoreThe gene therapy market is projected to be worth USD 14.6 billion in 2030, claims Roots Analysis
Driven by the potential to treat the root cause of diseases, including rare clinical conditions and those that were previously …
Read MoreHuman Microbiome-based Products Market is growing at an annualized rate of over 40%.
Over the years, extensive R&D efforts have established the basis for a wide range of microbiome-based therapeutic and diagnostic products, …
Read More